Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Subjects With Renal Impairment”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT04194671
What this trial is testing

Clinical Trial of Mesenchymal Stem Cells in the Treatment of Severe Acute Kidney Injury

Who this might be right for
Acute Kidney InjuryMesenchymal Stem Cells
Chinese PLA General Hospital 80
Early research (Phase 1)Study completedNCT01120314
What this trial is testing

Pharmacokinetic, Pharmacodynamic and Tolerability Study of Otamixaban in Patients With Mild, Moderate and Severe Renal Impairment

Who this might be right for
Renal Impairment
Sanofi 48
Early research (Phase 1)Study completedNCT01761773
What this trial is testing

A Single-Dose Study to Assess the Pharmacokinetics of Cabozantinib (XL184) Capsules in Subjects With Impaired Renal Function

Who this might be right for
HealthyRenal Impairment
Exelixis 32
Large-scale testing (Phase 3)WithdrawnNCT04162366
What this trial is testing

A Research Study to Show Aprocitentan is Efficacious and Safe to Treat Patients With Uncontrolled Blood Pressure and Chronic Kidney Disease.

Who this might be right for
HypertensionRenal Insufficiency, Chronic
Idorsia Pharmaceuticals Ltd.
Not applicableUnknownNCT06086470
What this trial is testing

Evaluating the Use of the Qidni/D Hemodialysis System by Subjects With End-Stage Renal Disease

Who this might be right for
Kidney Disease, End-Stage
Qidni Labs Inc. 30
Early research (Phase 1)Study completedNCT04303156
What this trial is testing

Pharmacokinetics of Islatravir in Participants With Severe Renal Impairment (MK-8591-026)

Who this might be right for
Human Immunodeficiency Virus (HIV) Infection
Merck Sharp & Dohme LLC 12
Early research (Phase 1)Study completedNCT01006057
What this trial is testing

A Trial Investigating the NN1250 Concentration-time Curve in Subjects With Various Degrees of Renal Impairment and in Subjects With Normal Renal Function

Who this might be right for
DiabetesHealthy
Novo Nordisk A/S 32
Early research (Phase 1)Study completedNCT03311841
What this trial is testing

Pharmacokinetics of Midazolam, Dabigatran, Pitavastatin, Atorvastatin, and Rosuvastatin in Participants With Renal Insufficiency in the Presence and Absence of Rifampin (MK-0000-386)

Who this might be right for
Renal Insufficiency
Merck Sharp & Dohme LLC 32
Early research (Phase 1)Study completedNCT00935831
What this trial is testing

Single Dose Safety Study for Compound to Treat Anemia in Patients With Renal Impairment

Who this might be right for
Kidney Disease
GlaxoSmithKline 12
Large-scale testing (Phase 3)Study completedNCT00858637
What this trial is testing

Efficacy and Safety Study of MCI-196 Versus Simvastatin for Dyslipidaemia in Chronic Kidney Disease (CKD) Subjects on Dialysis

Who this might be right for
Chronic Kidney Disease
Tanabe Pharma Corporation 260
Early research (Phase 1)Study completedNCT02852239
What this trial is testing

Pharmacokinetics of Dabrafenib in Subjects With Renal Impairment

Who this might be right for
Renal Impairment
Novartis Pharmaceuticals 22
Large-scale testing (Phase 3)Study completedNCT01309828
What this trial is testing

Long-Term Safety of Azilsartan Medoxomil and Chlorthalidone Compared to Olmesartan Medoxomil and Hydrochlorothiazide in Participants With Hypertension and Kidney Disease

Who this might be right for
Safety
Takeda 153
Testing effectiveness (Phase 2)Study completedNCT00548249
What this trial is testing

Dose Ranging Study of Dialysate Containing Soluble Iron to Treat Subjects With End Stage Renal Disease (ESRD) Receiving Chronic Hemodialysis

Who this might be right for
End-Stage Renal Disease (ESRD)
Rockwell Medical Technologies, Inc. 131
Large-scale testing (Phase 3)Study completedNCT02273726
What this trial is testing

Study to Evaluate the Efficacy and Safety of Roxadustat in the Treatment of Anemia in Participants With ESRD on Stable Dialysis

Who this might be right for
CKD Anemia in Stable Dialysis Patients
Kyntra Bio 741
Early research (Phase 1)Study completedNCT02085538
What this trial is testing

Study Of Palbociclib (PD-0332991) In Renal Impairment

Who this might be right for
Renal Impairment
Pfizer 31
Post-approval studies (Phase 4)Ended earlyNCT01104662
What this trial is testing

Study of Daptomycin Safety and Efficacy for Complicated Skin and Skin Structure Infections (cSSSI) and Bacteremia in Renal Impairment

Who this might be right for
Complicated Skin and Skin Structure InfectionsS. Aureus BacteremiaRenal Impairment
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 92
Early research (Phase 1)Study completedNCT06529796
What this trial is testing

Evaluation of the Pharmacokinetics and Safety of Inaxaplin in Participants With Mild or Moderate Hepatic Impairment

Who this might be right for
Focal Segmental Glomerulosclerosis (FSGS)
Vertex Pharmaceuticals Incorporated 36
Early research (Phase 1)Study completedNCT02399202
What this trial is testing

A Phase I Study of Osilodrostat (LCI699) in Healthy Volunteers and Subjects With Impaired Renal Function

Who this might be right for
Renal Impairment
Novartis Pharmaceuticals 15
Large-scale testing (Phase 3)Study completedNCT01537042
What this trial is testing

A Sleep Laboratory Study to Investigate the Safety and Efficacy of the Rotigotine Skin Patch in Subjects With Restless Legs Syndrome and End-Stage Renal Disease Requiring Hemodialysis

Who this might be right for
Restless Legs SyndromeEnd-Stage Renal Disease
UCB BIOSCIENCES GmbH 30
Testing effectiveness (Phase 2)Study completedNCT00317694
What this trial is testing

Efficacy and Safety Study of Magnesium Iron Hydroxycarbonate for the Reduction of High Blood Phosphate in Hemodialysis Patients

Who this might be right for
Chronic Kidney Failure
Ineos Healthcare Limited 111
Next Page